Dose-escalation study of weekly irinotecan and daily carboplatin with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer.
about
Phase I study of celecoxib with concurrent irinotecan, Cisplatin, and radiation therapy for patients with unresectable locally advanced non-small cell lung cancerDNA topoisomerase I drugs and radiotherapy for lung cancer.New and emerging radiosensitizers and radioprotectors.Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer.
P2860
Dose-escalation study of weekly irinotecan and daily carboplatin with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Dose-escalation study of weekl ...... II non-small cell lung cancer.
@ast
Dose-escalation study of weekl ...... II non-small cell lung cancer.
@en
type
label
Dose-escalation study of weekl ...... II non-small cell lung cancer.
@ast
Dose-escalation study of weekl ...... II non-small cell lung cancer.
@en
prefLabel
Dose-escalation study of weekl ...... II non-small cell lung cancer.
@ast
Dose-escalation study of weekl ...... II non-small cell lung cancer.
@en
P2093
P2860
P356
P1476
Dose-escalation study of weekl ...... II non-small cell lung cancer.
@en
P2093
K Nakagawa
N Yamamoto
Y Nishimura
P2860
P2888
P304
P356
10.1038/SJ.BJC.6600464
P407
P577
2002-07-01T00:00:00Z
P5875
P6179
1041119195